[Federal Register Volume 74, Number 64 (Monday, April 6, 2009)]
[Notices]
[Pages 15499-15500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7724]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting

    The Diabetes Mellitus Interagency Coordinating Committee (DMICC) 
will hold a meeting on May 6, 2009, from 12:30 to 4:30 p.m. at Building 
31C, Conference Room 6C, on the NIH campus, 9000 Wisconsin Ave., 
Bethesda, MD. The meeting will be open to the public, with attendance 
limited to space available. Non-federal individuals planning to attend 
the meeting should notify the Contact Person listed on this notice at 
least 2 days prior to the meeting. Individuals who plan to attend and 
need special assistance, such as sign language interpretation or other 
reasonable accommodations, should inform the Contact Person listed 
below at least 10 days in advance of the meeting.
    The DMICC facilitates cooperation, communication, and collaboration 
on diabetes among government entities. DMICC meetings, held several 
times a year, provide an opportunity for members to learn about and 
discuss current and future diabetes programs in DMICC member 
organizations and to identify opportunities for collaboration. The May 
6, 2009, DMICC meeting will discuss ``Federally Supported Diabetes-
Related National Education Programs.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present

[[Page 15500]]

oral comments and presentations will be limited to a maximum of five 
minutes. Both printed and electronic copies are requested for the 
record. In addition, any interested person may file written comments 
with the Committee by forwarding their statement to the Contact Person 
listed on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. Because of time constraints for 
the meeting, oral comments will be allowed on a first come, first 
served basis.

    Please Note:  The NIH has instituted security measures to ensure 
the safety of NIH employees and property. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport). All visitors should be prepared to 
have their personal belongings inspected and to go through metal 
detection inspection. Visitors are strongly encouraged to take 
public transportation to the NIH campus, as there are very few 
visitor parking spaces available. NIH Building 31C is a 10-minute 
walk from the Medical Center Station on the Red Line of the Metro.

    A registration link and information about the DMICC meeting will be 
available on the DMICC Web site: http://www.diabetescommittee.gov. 
Members of the public who would like to receive e-mail notification 
about future DMICC meetings could register on a listserv available on 
the same Web site.
    For further information concerning this meeting, contact Dr. 
Sanford Garfield, Executive Secretary of the Diabetes Mellitus 
Interagency Coordinating Committee, National Institute of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 
5460, Bethesda, MD 20892-5460, Telephone: 301-594-8803, fax: 301-402-
6271, E-mail: [email protected].

    Dated: April 1, 2009.
Sanford Garfield, PhD,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and 
Metabolic Diseases, NIDDK, National Institutes of Health.
 [FR Doc. E9-7724 Filed 4-3-09; 8:45 am]
BILLING CODE 4140-01-P